EMEA-001050-PIP01-10-M05

Key facts

Invented name
Taltz
Active substance
ixekizumab
Therapeutic area
Dermatology
Decision number
P/0087/2020
PIP number
EMEA-001050-PIP01-10-M05
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of psoriasis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Eli Lilly Nederland B.V.

E-mail: EU_paediatric@lilly.com
Tel.  +44 1276483000

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating